Kurum Yazarı "Çakır, Aslı" Bildiri Koleksiyonu İçin Listeleme
-
Adult case series of extramedullary relapsing acute myeloid leukemia (AML) after allogeneic stem cell transplantation in whom a rapid response and a reasonably long remission could be achieved with gemtuzumab ozogamycin (GO)
Sevindik, Ömür Gökmen; Gemici, Aliihsan; Usta, Furkan Selim; Çakır, Aslı; Sadri, Sevil; Bekoz, Hüseyin; Sargın, Fatma Deniz (The American Society of Hematology, 2019)Gemtuzumab Ozogamycin (GO) is a drug conjugated monoclonal antibody which targets CD33 an antigen highly expressed on the surface of AML blasts. GO is approved for the treatment of both newly-diagnosed and relapsed AML. ... -
Case report of a primary renal vein leiomyosarcoma
Yılmaz Erözbek, Sıla; Çakır, Aslı; Dervişoğlu, Sergülen (Springer, 2022)... -
NTRK-rearranged spindle cell neoplasm: A case report
Yılmaz Erözbek, Sıla; Çakır, Aslı; Dervişoğlu, Sergülen (Springer, 2022)... -
Primary leiomyosarcoma of the stomach: A case report
Özden, Ferhat; Çakır, Aslı (Springer, 2022)... -
The relationship between the change with neoadjuvant chemotherapy in the tumor-infiltrating lymphocyte (TIL) expressions and pathological response in breast cancer patients.
Bilici, Ahmet; Göktaş Aydın, Sabin; Çakır, Aslı; Ölmez, Ömer Fatih; Erol, Vedat Buğra (Lippincott Williams & Wilkins, 2023)...